Atara Biotherapeutics Inc (ATRA)
0.6716
-0.02
(-2.91%)
USD |
NASDAQ |
Apr 19, 16:00
0.6717
0.00 (0.00%)
After-Hours: 20:00
Atara Biotherapeutics Cash from Financing (TTM): 2.01M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.01M |
September 30, 2023 | 32.79M |
June 30, 2023 | 32.78M |
March 31, 2023 | 33.47M |
December 31, 2022 | 53.08M |
September 30, 2022 | 72.26M |
June 30, 2022 | 119.61M |
March 31, 2022 | 120.90M |
December 31, 2021 | 103.94M |
September 30, 2021 | 231.27M |
June 30, 2021 | 217.64M |
March 31, 2021 | 406.51M |
December 31, 2020 | 427.57M |
September 30, 2020 | 286.23M |
June 30, 2020 | 398.66M |
March 31, 2020 | 214.67M |
December 31, 2019 | 188.79M |
September 30, 2019 | 157.36M |
June 30, 2019 | 10.91M |
March 31, 2019 | 59.60M |
December 31, 2018 | 357.54M |
Date | Value |
---|---|
September 30, 2018 | 352.21M |
June 30, 2018 | 362.60M |
March 31, 2018 | 316.38M |
December 31, 2017 | 20.05M |
September 30, 2017 | 19.68M |
June 30, 2017 | 10.01M |
March 31, 2017 | 0.198M |
December 31, 2016 | 0.506M |
September 30, 2016 | 0.36M |
June 30, 2016 | 194.22M |
March 31, 2016 | 189.72M |
December 31, 2015 | 259.23M |
September 30, 2015 | 317.13M |
June 30, 2015 | 122.52M |
March 31, 2015 | 126.29M |
December 31, 2014 | 70.27M |
September 30, 2014 | 50.60M |
June 30, 2014 | 51.15M |
March 31, 2014 | 53.38M |
December 31, 2013 | 53.38M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.01M
Minimum
Dec 2023
427.57M
Maximum
Dec 2020
163.71M
Average
120.90M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |